Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report

Author:

Cable Jennifer1,Fauci Anthony2,Dowling William E.3,Günther Stephan4,Bente Dennis A.56,Yadav Pragya Dhruv7,Madoff Lawrence C.8,Wang Lin‐Fa9,Arora Rahul K.1011,Van Kerkhove Maria12,Chu May C.13,Jaenisch Thomas13,Epstein Jonathan H.14,Frost Simon David William15,Bausch Daniel G.16,Hensley Lisa E.1718,Bergeron Éric19,Sitaras Ioannis20,Gunn Michael D.21,Geisbert Thomas W.2223,Muñoz‐Fontela César4,Krammer Florian24,de Wit Emmie25,Nordenfelt Pontus26,Saphire Erica Ollmann27,Gilbert Sarah C.28,Corbett Kizzmekia S.29,Branco Luis M.30,Baize Sylvain313233,van Doremalen Neeltje25,Krieger Marco A.3435,Clemens Sue Ann Costa3637,Hesselink Renske3,Hartman Dan38

Affiliation:

1. PhD Science Writer New York New York USA

2. Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) Bethesda Maryland USA

3. Coalition for Epidemic Preparedness Innovations (CEPI) Oslo Norway

4. Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research Hamburg Germany

5. University of Texas Medical Branch Galveston National Laboratory Galveston Texas USA

6. Division of Biology and Biological Engineering California Institute of Technology Pasadena California USA

7. Indian Council of Medical Research‐National Institute of Virology Pune India

8. Department of Medicine University of Massachusetts Chan School of Medicine Worcester Massachusetts USA

9. Duke‐NUS Medical School Singapore

10. Department of Community Health Sciences University of Calgary Calgary Alberta Canada

11. Institute of Biomedical Engineering University of Oxford Oxford UK

12. World Health Organization Geneva Switzerland

13. Colorado School of Public Health Anschutz Medical Campus Aurora Colorado USA

14. EcoHealth Alliance New York New York USA

15. Microsoft Research Redmond Washington USA

16. FIND, the global alliance for diagnostics Geneva Switzerland

17. Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) Monrovia Liberia

18. Division of Clinical Research National Institute of Allergy and Infectious Diseases Bethesda Maryland USA

19. Viral Special Pathogens Branch, Division of High‐Consequence Pathogens and Pathology Centers for Disease Control and Prevention Atlanta Georgia USA

20. W. Harry Feinstone Department of Molecular Microbiology and Immunology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA

21. Department of Medicine Duke University Medical Center Durham North Carolina USA

22. University of Manitoba Winnipeg Manitoba Canada

23. Galveston National Laboratory and Department of Microbiology and Immunology University of Texas Medical Branch Galveston Texas USA

24. Department of Microbiology and Department of Pathology Icahn School of Medicine at Mount Sinai New York New York USA

25. Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases National Institutes of Health Hamilton Montana USA

26. Department of Clinical Sciences Lund, Infection Medicine, Faculty of Medicine Lund University Lund Sweden

27. Center for Infectious Disease and Vaccine Research La Jolla Institute for Immunology La Jolla California USA

28. Pandemic Sciences Institute, Nuffield Department of Medicine University of Oxford Oxford UK

29. Department of Immunology and Infectious Diseases Harvard T.H. Chan School of Public Health Boston Massachusetts USA

30. Zalgen Labs Germantown Maryland USA

31. Unité de Biologie des Infections Virales Emergentes Institut Pasteur Lyon France

32. Centre International de Recherche en Infectiologie (CIRI) Lyon France

33. INSERM, Ecole Normale Supérieure de Lyon Université de Lyon Lyon France

34. Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute Oswaldo Cruz Foundation ‐ Paraná Curitiba Brazil

35. Integrated Translational Program in Chagas Disease from Fiocruz (Fio‐Chagas) Oswaldo Cruz Foundation ‐ Rio de Janeiro Rio de Janeiro Brazil

36. Oxford Vaccine Group Oxford University Oxford UK

37. Institute for Global Health University of Siena Siena Italy

38. Bill & Melinda Gates Foundation Seattle Washington USA

Funder

National Institute of Allergy and Infectious Diseases

Canadian Medical Association

Public Health Agency of Canada

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference91 articles.

1. Novel 2019 coronavirus genome ‐ SARS‐CoV‐2 coronavirus. (2020).Virological.https://virological.org/t/novel‐2019‐coronavirus‐genome/319

2. Classification of Omicron (B.1.1.529): SARS‐CoV‐2 Variant of Concern. (2022).https://www.who.int/news/item/26‐11‐2021‐classification‐of‐omicron‐(b.1.1.529)‐sars‐cov‐2‐variant‐of‐concern

3. National Institutes of Health.NIH launches clinical trials network to test COVID‐19 vaccines and other prevention tools. (2020).https://www.nih.gov/news‐events/news‐releases/nih‐launches‐clinical‐trials‐network‐test‐covid‐19‐vaccines‐other‐prevention‐tools

4. The Critical Role of Biomedical Research in Pandemic Preparedness

5. Prototype pathogen approach for pandemic preparedness: world on fire

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3